reduce basal insulin dose when starting glp-1 receptor agonist Titration algorithm for New Developments in Pharmacological Treatment
Description
Its predominant action is on the postprandial glucose levels, with extraglycemic effects on fat metabolism and endovascular function
Discover everything you need to know about GLP-1, from its biological functions and health benefits to weight loss, natural boosters, and medications.
ICD-10 codes to identify the outcome are included in supplementary table S1
Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc
